Kyverna Therapeutics (KYTX) Stock Price Target 2026

The average analyst price target for Kyverna Therapeutics is $21.67, 344.1% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $5 to $33. The latest change came on May 15, 2026, when HC Wainwright & Co. raised its price target on Kyverna Therapeutics from $20 to $25 and kept a Buy rating.